๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Lymphatic Malformation

Cerebrovascular Reactivity Measurements With High-Density Diffuse Optical Tomography NCT07776444NA1 site๐Ÿ“ St Louis Washington University School of Medicine ยท Tests: Carbon Dioxide School Readiness Intervention for Preschool Children With Sickle Cell Disease NCT06367192NA1 site๐Ÿ“ Memphis St. Jude Children's Research Hospital ยท Tests: The adapted Kids in Transition to School Intervention, Standard school resources Sickle Cell Disease Biofluid Chip Technology (SCD BioChip) NCT02824471n/a1 site๐Ÿ“ Cleveland University Hospitals Cleveland Medical Center ยท Tests: SCD Group PASS of Xromi Comparing Safety and Effectiveness in Children Under 2 Years With Sickle Cell Disease [PRECISE PASS] NCT06923111n/a12 sites๐Ÿ“ Hamburg๐Ÿ“ Heidelberg๐Ÿ“ Basildon Nova Laboratories Limited ยท Tests: Xromi Atrial Fibrillation in Beta-Thalassemia NCT05508932n/a1 site๐Ÿ“ Ferrara University Hospital of Ferrara A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke NCT05953584Phase 29 sites๐Ÿ“ Raipur๐Ÿ“ Delhi๐Ÿ“ Gujarat Forma Therapeutics, Inc. ยท Tests: Etavopivat, Hydroxyurea A Prospective Study on the Role of Karl Storz Curved and Straight Fetoscopes (11508AAK and 11506AAK) for Fetoscopic Intrauterine Procedures NCT06056635NA1 site๐Ÿ“ Boston Boston Children's Hospital ยท Tests: Karl Storz Curved Scope, Karl Storz Straight Scope A Phase 2 Study of Mutant-selective PI3Kฮฑ Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study) NCT06789913Phase 240 sites๐Ÿ“ Phoenix๐Ÿ“ Little Rock๐Ÿ“ Los Angeles Relay Therapeutics, Inc. ยท Tests: RLY-2608, Placebo Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families NCT00230620n/a1 site๐Ÿ“ London Imperial College London Hemlibra in Mild Hemophilia A NCT04567511Phase 41 site๐Ÿ“ Indianapolis Indiana Hemophilia &Thrombosis Center, Inc. ยท Tests: Emicizumab Pediatric Orthopaedic Implant Safety & Efficacy NCT05361980n/a1 site๐Ÿ“ Vancouver University of British Columbia ยท Tests: Pediatric orthopaedic implant Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (ฮฒ)-Thalassemia NCT04143724Phase 226 sites๐Ÿ“ Los Angeles๐Ÿ“ New York๐Ÿ“ Guangzhou Celgene ยท Tests: ACE-536 Investigation of the Genetics of Hematologic Diseases NCT02720679n/a1 site๐Ÿ“ Memphis St. Jude Children's Research Hospital Adiposity and Iron Requirements in Pregnancy NCT06425796NA3 sites๐Ÿ“ Coleraine๐Ÿ“ Coleraine๐Ÿ“ Coleraine University of Ulster ยท Tests: Adiposity and Iron Requirements in Pregnancy (ADIPREG) Tocilizumab for Acute Chest Syndrome NCT05640271Phase 21 site๐Ÿ“ Chicago University of Chicago ยท Tests: Tocilizumab SMYLS Multi-site Trial NCT06035939NA1 site๐Ÿ“ Charleston Medical University of South Carolina ยท Tests: Voice Crisis Alert V2, Electronic educational materials Clinical Study of Super Transplantation in the Treatment of Severe ฮฒ-thalassemia NCT06734520NA2 sites๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Guangzhou Women and Children's Medical Center ยท Tests: super-transplantation in 3 severe ฮฒ -thalassemia pediatric patients. Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait NCT07083531n/a1 site๐Ÿ“ Farmington UConn Health ยท Tests: Healthy volunteers without SCT, Healthy volunteers with SCT Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease NCT07274254Phase 312 sites๐Ÿ“ Bordeaux๐Ÿ“ Bordeaux๐Ÿ“ Lille Nantes University Hospital ยท Tests: Lidocain, Placebo, Standard of care Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in ฮ’-thalassaemia Patients. NCT06655662Phase 13 sites๐Ÿ“ Guangxi๐Ÿ“ Shenzhen๐Ÿ“ Shenzhen Shenzhen Hemogen ยท Tests: ฮฒ-globin restored autologous hematopoietic stem cells A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia NCT06609226Phase 3107 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Los Angeles Novo Nordisk A/S ยท Tests: Etavopivat A, Etavopivat B, Etavopivat C A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab NCT06145373Phase 43 sites๐Ÿ“ Los Angeles๐Ÿ“ Flowood๐Ÿ“ Taipei Sanofi ยท Tests: Fitusiran (SAR439774), Clotting factor concentrates (CFC) or bypassing agents (BPA), Antithrombin concentrate (ATIIIC),โ€ฆ Serial Assessment of Fertility Experiences NCT07116772n/a3 sites๐Ÿ“ Santo Domingo๐Ÿ“ Kingston๐Ÿ“ Mwanza Children's Hospital Medical Center, Cincinnati Long-term Follow-up Study of BHC001 for TDT NCT06314529n/a2 sites๐Ÿ“ Nanning๐Ÿ“ Changsha Bioray Laboratories ยท Tests: Assessments Blood Sampling for Research Related to Sickle Cell Disease NCT00542230n/a1 site๐Ÿ“ Bethesda National Institute of Diabetes and Digestive and Kidney Disโ€ฆ Sickle-cell Disease Registry of the GPOH NCT03327428n/a1 site๐Ÿ“ Heidelberg University Hospital Heidelberg Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531) NCT07136857Phase 21 site๐Ÿ“ Atlanta Emory University ยท Tests: EPTACOG BETA Breath-holding Spells and Its Management Study NCT06628271NA12 sites๐Ÿ“ Eslรถv๐Ÿ“ Kristianstad๐Ÿ“ Lund Region Skane ยท Tests: Guidelines A Long-term Follow-up Study in Patients Who Received BEAM-101 NCT07373639n/a17 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Jacksonville Beam Therapeutics Inc. ยท Tests: Long-Term Follow-up Study of patients who received BEAM-101 Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease NCT03587272Phase 27 sites๐Ÿ“ Washington D.C.๐Ÿ“ Chicago๐Ÿ“ New York Robert Nickel ยท Tests: Alemtuzumab, low dose total body irradiation, Sirolimus
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy